April 14, 2000 - Volume 14 - Issue 6
pp: 629-759
Subscribe to eTOC


Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.; More

AIDS . 14(6):659-669, April 14, 2000.

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

Eron, Joseph J.; Yetzer, Ellen S.; Ruane, Peter J.; More

AIDS . 14(6):671-681, April 14, 2000.


Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

Puig, Teresa; Pérez-Olmeda, Mayte; Rubio, Amalia; More

AIDS . 14(6):727-732, April 14, 2000.